Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
19.07
+1.13 (6.30%)
At close: Jan 6, 2025, 4:00 PM
19.20
+0.13 (0.68%)
After-hours: Jan 6, 2025, 4:42 PM EST
ARCT Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ARCT stock have an average target of 65, with a low estimate of 48 and a high estimate of 86. The average target predicts an increase of 240.85% from the current stock price of 19.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ARCT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +230.36% | Dec 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +230.36% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +230.36% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
Financial Forecast
Revenue This Year
179.02M
from 166.80M
Increased by 7.33%
Revenue Next Year
187.45M
from 179.02M
Increased by 4.71%
EPS This Year
-2.50
from -1.12
EPS Next Year
-2.02
from -2.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 232.2M | 268.0M | 937.9M | |||
| Avg | 179.0M | 187.5M | 347.2M | |||
| Low | 136.7M | 88.8M | 141.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 39.2% | 49.7% | 400.4% | |||
| Avg | 7.3% | 4.7% | 85.2% | |||
| Low | -18.0% | -50.4% | -24.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.35 | 3.28 | 9.50 | |||
| Avg | -2.50 | -2.02 | 0.78 | |||
| Low | -3.08 | -5.05 | -5.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.